Jolanta Kupryjanczyk

6PUBLICATIONS
73CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 25, 2025
High Frequency of PIK3R1 Alterations in Ovarian Cancers: Clinicopathological and Molecular Associations.

Iwona K Rzepecka, Andrzej Tysarowski, Bozena Konopka

|Oct 26, 2024
The Diversity of Methylation Patterns in Serous Borderline Ovarian Tumors and Serous Ovarian Carcinomas.

Laura A Szafron, Roksana Iwanicka-Nowicka, Piotr Sobiczewski

|Dec 23, 2022
Microfibril Associated Protein 5 (MFAP5) Is Related to Survival of Ovarian Cancer Patients but Not Useful as a Prognostic Biomarker.

Katarzyna Aleksandra Kujawa, Ewa Zembala-Nożynska, Joanna Patrycja Syrkis

|Nov 04, 2020
Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers.

Dylan M Glubb, Deborah J Thompson, Katja K H Aben

|Jan 16, 2020
Fibronectin and Periostin as Prognostic Markers in Ovarian Cancer.

Katarzyna Aleksandra Kujawa, Ewa Zembala-Nożyńska, Alexander Jorge Cortez

|Mar 02, 2019
Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas.

Joanna Moes-Sosnowska, Iwona K Rzepecka, Joanna Chodzynska

Pageof 1